Drug Discovery is ELRIG’s flagship event. Now in its 11th year, we return to ACC in Liverpool to bring together the leading lights in drug discovery research across pharma, biotech, academia and the vendor community.
The meeting will feature over 50 world-class speakers in 6 main session tracks, each highlighting the latest scientific breakthroughs and new approaches that are driving this success. This conference will explore innovative technologies and approaches that can be used to overcome drug development challenges, and bring together industry leaders who will discuss future opportunities for novel therapeutic discovery. Scientific tracks will cover:
- Innovations in Chemistry
- Target Identification and Validation
- Innovations in Assay Design, Development and Screening
- Advances in Imaging
- Drug Discovery in the 4th Dimension
- From Molecule to Man: Right dose, first time
There will also be a series of vendor workshops, which will provide a more informal, interactive environment for you to discuss key issues and future directions in workshops coordinated by leaders in the fields. Drug Discovery 2017 will include a high quality scientific poster session, networking opportunities, and an extensive vendor exhibition featuring around 100 companies. And don’t miss the Innovation Zone, for new and exciting emerging companies and technologies.
Plenary keynote speakers
Dr. Mene Pangalos (Executive Vice-President, IMED Biotech Unit, AstraZeneca)
Dr. Nessa Carey (International Director at PraxisUnico , Visiting Professor at Imperial College, and author)
Innovations in Assay Design, Development and Screening – download pdf session summary
This session will explore the latest advances in assay technologies and screening paradigms, supported by impactful case studies.
Drug Discovery in the 4th Dimension – download pdf session summary
It is becoming more widely appreciated that ligand binding and signalling kinetics play an important role in defining clinical efficacy and duration of drug action. For this reason, many drug discovery programmes are incorporating kinetics assays early in the process to establish structure-kinetic relationships. This session will explore the most successful paradigms and methodologies currently utilised to study the role of kinetics on clinical outcome.
Advances in Imaging – download pdf session summary
The Imaging session will be designed to embrace all scales of discovery and development. From whole body studies, through to new approaches to visualising tissues, cells, proteins and single molecules. How might our ability to view, investigate and interrogate the biology of disease enable us to better diagnose and treat patients?
Innovations in Chemistry – download pdf session summary
This session will capture the latest advances in Medicinal Chemistry and Chemical Biology.
Target Identification and Validation – download pdf session summary
Selecting, and validating, the right target(s) is crucial to all drug discovery campaigns. This session will explore the latest ideas and technology advances which are helping to dissect the molecular mechanisms of disease.
From Molecule to Man: right dose, first time – download pdf session summary
Predicting the right dose of a drug, at the right time, to the right patient population is still a key challenge. This session will focus on in silico and experimental advances which will enable improved translatability of drug therapies from the lab to the Patient.
Rachel Grimley (AstraZeneca)
Tim Hammonds (Cancer Research Technology)
Steve Charlton (University of Nottingham)
Innovations in Chemistry
Chris Schofield (University of Oxford)
Matt Tozer (Cyclofluidic)
Target Identification and Validation
Darren Cawkill (Apollo Therapeutics)
Louise Jones (MRC)
Innovations in Assay Design, Development and Screening
Helen Boyd (AstraZeneca)
Florian Fuchs (Novartis)
Advances in Imaging
Richard Bayliss (University of Leeds)
Neil Carragher (University of Edinburgh)
Drug Discovery in the 4th Dimension
Jon Hutchinson (GlaxoSmithKline)
David Swinney (iRND3)
From Molecule to Man: Right dose, first time
Pinky Dua (Pfizer)
Piet Van der Graaf (Leiden University)
Vendor workshops at Drug Discovery 2017 provide an informal, interactive environment for discussions on key issues and future directions by leaders in the fields. These include:
- Lab of the Future Workshop: sponsored by SiLA – download the flyer
From laborious data transfer and incorrect user settings, to poor utilization and uptime, the lab today can be a frustrating place to work! The future promises to be bright, but what will the lab look like? Can our labs benefit from the revolution of the Internet of Things and concepts from Industry 4.0?
This innovative workshop will bring together users and suppliers for a fresh discussion on trends and ideas that could influence the lab of the future and make it a more pleasant, safe and productive place to work. In this workshop, we will explore how labs could evolve from user and automation perspectives and the associated challenges with interoperability and data handling that this may bring.
SLAS Author Workshop presented by Rob Howes (AstraZeneca) – download the flyer
Join SLAS for a step-by-step overview of how to design and write scientific research papers more clearly and effectively to improve their chances for publication. Learn what editors want, what they don’t want, common mistakes, insider tips and how reviewers evaluate manuscripts. Presented by SLAS Discovery Editorial Board member and guest editor Rob Howes, PhD, of AstraZeneca in Sweden.
BPS Workshop: Driving Drug Discovery through novel industry-academic engagement – download the flyer
The objective of this workshop is to increase awareness of a broad range of activities that have been developed to promote industry-academic drug discovery. As pharma companies streamline their internal operations they are increasingly turning to academia to support their research efforts. Innovative models for collaboration have been developed and are facilitating two-way access to expertise, tools and platforms in a bid to accelerate drug discovery. Pharma companies are differentiating themselves in a bid to become a “partner of choice” for strong academic groups.
The session will highlight a diverse range of truly innovative models of engagement. Talks will be short and will be followed by a guided panel discussion in order to maximise audience participation and engagement.
Workshop: Cutting-edge cellular analysis techniques: case studies in drug discovery – download the flyer
Cellular analysis and cell-based assays are central to scientific discovery and the hunt for new biomedicines. Increasingly, more complex and advanced cell models are employed, including co-culture systems, iPSC-derived and patient specific tissue organoids. This raises the bar for assay development and functional profiling methods that are able to extract the deeper content provided by these models, without compromising efficiency and productivity.
In this workshop, we will discuss the latest developments in two ground breaking cellular analysis solutions: IncuCyte® live-cell analysis and iQue® Screener PLUS high throughput suspension cell analysis platform. The workshop is targeted toward researchers with general interest in translational cell models, cell-based assays, cancer biology and immunology, including current and prospective users.
For Poster Presenters
Poster presentations at Drug Discovery 2017 are an excellent opportunity for delegates to network with colleagues and communicate their research FREE OF CHARGE. To be considered for a poster presentation, you must first submit an abstract for review by the meeting’s Scientific Program Committee.
For those wishing to participate, a subset of abstracts will also be considered for a short, poster taster session involving a 10 minute oral presentation within the main Symposia sessions. Decisions regarding acceptance of poster abstracts and/or selection for Poster Tasters will be communicated via e-mail in mid-September.
Deadlines for Submission:
25th August 2017: Poster Taster Spot
22nd September 2017: General Poster Submission
All presenters must be registered as full-conference attendees in order to present at Drug Discovery 2017.
Poster size should be no larger than A0 Portrait (W: 841mm x H: 1189mm).
ELRIG organizers will provide supplies to mount your posters, including Velcro and/or pushpins.
We apologise that we are unable to accommodate posters which are any larger than A0 Portrait.
Posters from Exhibiting Companies:
As an exhibitor, you have one poster spot included with your stand package.
Additional poster spots are £250 +VAT each.
Posters from Non-Exhibiting Companies:
Non-exhibiting vendor companies will be charged £250 +VAT for each poster submitted.
The speaker’s reception will take place on Tuesday 2nd October 2017 with drinks at 7pm and buffet from 7.30pm. The reception will be held at:
The Pullman Hotel
Kings Dock, Monarchs Quay,
Liverpool L3 4FP
0151 945 1000
Part of the mission of ELRIG is encourage and foster new technologies, from innovative companies. To help do this, ELRIG provide “The Innovation Zone,” within some of its major events. The Innovation Zone, gives up-and-coming companies, with new technologies or services, who cannot afford a full stand, access to a major event and critical exposure to the market.
This helps ELRIG to create a more diverse and interesting show, which in turn leads to greater delegate engagement.
The Innovation Zone has a prime location, and companies and products in the Innovation Zone will feature in the programme and on the ELRIG app along with a brief profile and a link to your own site, giving some free advertising courtesy of ELRIG.
For full details of the Innovation Zone qualifying criteria, click here